NFIB and adrenal cortex carcinoma: Finally, the identification of a fusion between MYBL1 and NFIB genes in tumors without MYB aberration [6, 7], demonstrates that the pathogenesis of ACC may be driven by genetic alterations in another member of the same transcription factor (TF) gene family.